NIH-funded research R01 grant

Investigating how a specific receptor affects liver disease in women with alcohol use.

Official title: Human pregnane X receptor and sexual dimorphism in alcoholic liver disease

Funded at University of Tennessee Health Sci Ctr · NIH-10883611 · Data updated 2026-11-12

This study is looking into why women with alcoholic liver disease tend to have more severe symptoms than men, focusing on how certain biological factors and hormones affect liver health in women who drink alcohol.

More Alcoholic Liver Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tennessee Health Sci Ctr
NIH-funded
Lab location1 site (Memphis, United States)
Project startMay 1, 2022
Project endJune 30, 2025
Funding year2024
Award (this year)$346,500
NIH project number5R01AA028806-06
Project IDNIH-10883611 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women with a history of alcohol use who are experiencing or at risk for alcoholic liver disease.

Less likely to help

Patients who do not consume alcohol or have liver disease unrelated to alcohol may not benefit from this research.

What this research studies

This research focuses on understanding why alcoholic liver disease (ALD) is more severe in women compared to men. It examines the role of the human pregnane X receptor (PXR) and its influence on liver function and disease progression in females who consume alcohol. By studying the mechanisms behind alcohol metabolism and the impact of sex hormones, the research aims to uncover the biological differences that contribute to higher mortality rates in female alcoholics. The approach includes both human and animal models to explore the genetic and biochemical pathways involved in ALD.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and preventive measures for women suffering from alcoholic liver disease.

How similar studies have gone: Previous research has indicated significant differences in alcohol metabolism between sexes, suggesting that this area of investigation could yield valuable insights.

Where this research is happening

  • University of Tennessee Health Sci Ctr
    Memphis, United States
    Active

Researchers

  • Principal investigator: Gyamfi, Maxwell Afari — University of Tennessee Health Sci Ctr
  • Study coordinator: Gyamfi, Maxwell Afari

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.